Breaking News Instant updates and real-time market news.

BIIB

Biogen

$294.07

-8.7 (-2.87%)

, FWP

Forward Pharma

$22.13

0.18 (0.82%)

12:47
12/01/16
12/01
12:47
12/01/16
12:47

Biogen's Tecfidera patent feud may pose risk, WSJ says

Biogen (BIIB) faced oral arguments this week in a patent interference hearing brought by a small Danish biotech company, Forward Pharma (FWP), regarding "its best-selling multiple sclerosis drug, Tecfidera," says the Wall Street Journal. With analysts expecting Biogen to book almost $4B in Tecfidera sales this year, representing more than a third of total sales for the drug giant, a win by Forward Pharma would impact Biogen, added the WSJ. Also according to the report, sales of Biogen's other best selling drugs Avonex and Tysabri are slowing. Reference Link

BIIB

Biogen

$294.07

-8.7 (-2.87%)

FWP

Forward Pharma

$22.13

0.18 (0.82%)

  • 07

    Dec

BIIB Biogen
$294.07

-8.7 (-2.87%)

11/23/16
JEFF
11/23/16
NO CHANGE
Target $310
JEFF
Buy
Biogen selloff may be an overreaction, says Jefferies
Jefferies analyst Brian Abrahams believes selloff in shares of Biogen (BIIB) following Eli Lilly's (LLY) Alzheimer's failure may be an overreaction. Signals of activity seen for Lilly's sola "do maintain some possibility" that Biogen's aducanumab could "ultimately make it over the line," Abrahams tells investors in a research note. He keeps a Hold rating on Biogen with a $310 price target, however, viewing the risk/reward as balanced.
11/23/16
SBSH
11/23/16
NO CHANGE
Target $305
SBSH
Buy
Citi sees four reasons why Biogen Alzheimer's drug can still work
Citi analyst Robyn Karnauska sees four reasons why Biogen's (BIIB) Alzheimer's drug aducanumab can still work following the failure of Eli Lilly's (LLY) solanezumab. The analyst lists difference in mechanism of action, efficacy in an end-point-dependent manner, patient population and endpoints as why she thinks Biogen's drug can have a different outcome than Lilly's. The analyst has a Neutral rating on Biogen with a $305 price target.
11/23/16
MSCO
11/23/16
NO CHANGE
MSCO
Overweight
Morgan Stanley expects big reversal today in Biogen shares
Morgan Stanley Matthew Harrison expects shares of Biogen (BIIB) to end the trading day flat or slightly higher. The stock is currently down $26.61, or 8%, to $291.50 in pre-market trading. With Biogen's aducanumab more potent than Eli Lilly's solanezumab, the Alzheimer's drug still has potential for success, Harrison tells investors in a research note. He points out that Lilly management noted that "the study results, including many secondary clinical endpoints, directionally favored solanezumab." Harrison sees hope in the amyloid hypothesis. The analyst has an Overweight rating on Biogen.
11/23/16
PIPR
11/23/16
NO CHANGE
PIPR
Overweight
Piper's Schimmer proclaims amyloid hypothesis is not dead
Piper Jaffray analyst Joshua Schimmer says the failure of Eli Lilly's (LLY) solanezumab is not the final nail in the amyloid hypothesis coffin. Biogen (BIIB) and Eisai's aducanimab study is the most potent approach for amyloid lowering, Schimmer tells investors in a research note. He points out that he was skeptical whether solanezumab's effect was adequate. "Our view of Alzheimer's for amyloid is informed not so much by the extremely sloppy science in that disease, but by consistent cause/effect signals across other amyloidosis," Schimmer writes. He believes today's selloff in shares of Biogen "creates some breathing room." The analyst recommends looking to build a position in Biogen after the stock settles down. Schimmer reiterates an Overweight rating on the shares with a $335 price target. The stock is down 8%, or $24.41, to $293.70 in pre-market trading.
FWP Forward Pharma
$22.13

0.18 (0.82%)

08/03/16
JMPS
08/03/16
NO CHANGE
JMPS
Forward has positive read through from Biogen speculation, says JMP Securities
JMP Securities analyst Jason Butler thinks that acquisition speculation regarding Biogen (BIIB) highlights "underappreciated value" in Forward Pharma's IP portfolio. He continues to believe that Forward is undervalued, and he keeps a $33 price target and Outperform rating on the shares.
04/11/16
SBSH
04/11/16
NO CHANGE
Target $345
SBSH
Buy
Citi calls potential Biogen hemophilia sale 'surprising and confusing'
Citi analyst Robyn Karnauskas admits being "surprised and confused" after Reuters reported Friday that Biogen (BIIB) is exploring a sale of its hemophilia business. The analyst estimates the business is worth $4.8B-$6.4B. Biogen could use the cash to acquire a bigger strategic asset and/or buybacks, or may be trying to make itself "lean and more attractive as a potential M&A target," Karnauskas tells investors in a research note. She believes, however, that a takeout of Biogen "may be hard" given the uncertainty related to the Forward Pharma (FWP) patent issue regarding Tecfidera. Since the hemophilia business is growing at a time when peers in the sector are looking to diversify, investors will likely be confused should the unit be sold, Karnauskas writes. She keeps a Buy rating on Biogen.
03/14/16
JMPS
03/14/16
NO CHANGE
JMPS
Forward Pharma has positive read through from patent ruling, says JMP Securities
After Biogen's (BIIB) '537 EU patent was revoked, JMP Securities thinks the news is positive for Forward Pharma (FWP). According to the firm, Forward now has the only patent in Europe for a 480 mg Dimethyl fumarate drug for the treatment of MS. The firm keeps a $33 price target and Outperform rating on Forward.
03/11/16
LEER
03/11/16
NO CHANGE
LEER
Outperform
Europe revoked Biogen's Tecfidera dosing patent, says Leerink
Leerink analyst Jason Gerberry points out that the European Patent Office yesterday revoked Biogen's (BIIB) Tecfidera dosing patent. The '537 patent in Europe is equivalent to the U.S. '514 patent subject to an ongoing patent interference versus Forward Pharma (FWP), Gerberry tells investors in a research note. The European Patent Office's detailed opinion explaining the rationale for the revocation has not yet published and may not be available for about a month, the analyst points out. He believes Europe's decision has "zero read-through" to the U.S. patent dispute between Forward and Biogen. Gerberry has an Outperform rating on Forward Pharma.

TODAY'S FREE FLY STORIES

AAL

American Airlines

$45.15

-0.07 (-0.15%)

, UAL

United Continental

$70.80

1.24 (1.78%)

15:02
04/24/17
04/24
15:02
04/24/17
15:02
Hot Stocks
David Dao attorney says also representing American Airlines passenger »

In a TODAY Show interview…

AAL

American Airlines

$45.15

-0.07 (-0.15%)

UAL

United Continental

$70.80

1.24 (1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

WFM

Whole Foods

$35.71

0.21 (0.59%)

15:01
04/24/17
04/24
15:01
04/24/17
15:01
Options
Notable implied volatility spike in Whole Foods as shares rally »

Notable implied…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

15:00
04/24/17
04/24
15:00
04/24/17
15:00
General news
Breaking General news story  »

Minneapolis Federal…

UTX

United Technologies

$116.15

1.155 (1.00%)

14:51
04/24/17
04/24
14:51
04/24/17
14:51
Options
United Tech attracts call buyers as shares rally to new highs »

United Tech attracts call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 26

    Apr

ABX

Barrick Gold

$19.21

-0.025 (-0.13%)

14:50
04/24/17
04/24
14:50
04/24/17
14:50
Options
Barrick Gold options imply 4.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

BCR

C.R. Bard

$303.97

50.9 (20.11%)

14:49
04/24/17
04/24
14:49
04/24/17
14:49
Downgrade
C.R. Bard rating change  »

C.R. Bard downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 06

    Jun

AAPL

Apple

$142.27

-0.17 (-0.12%)

14:48
04/24/17
04/24
14:48
04/24/17
14:48
Periodicals
Apple reduces App Store affiliated commission to 2.5% from 7%, TechCrunch says »

Apple has informed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

NVS

Novartis

$74.41

1.01 (1.38%)

, KO

Coca-Cola

$43.35

0.28 (0.65%)

14:46
04/24/17
04/24
14:46
04/24/17
14:46
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

NVS

Novartis

$74.41

1.01 (1.38%)

KO

Coca-Cola

$43.35

0.28 (0.65%)

MMM

3M

$193.96

2.46 (1.28%)

MCD

McDonald's

$134.52

1.11 (0.83%)

LMT

Lockheed Martin

$275.72

2.63 (0.96%)

DD

DuPont

$79.69

1.04 (1.32%)

BIIB

Biogen

$272.94

0.48 (0.18%)

CAT

Caterpillar

$97.04

2.72 (2.88%)

VLO

Valero

$67.08

1.85 (2.84%)

GLW

Corning

$27.53

0.51 (1.89%)

BHI

Baker Hughes

$58.59

0.91 (1.58%)

PCAR

PACCAR

$65.76

-0.12 (-0.18%)

NTRS

Northern Trust

$87.36

-0.09 (-0.10%)

FITB

Fifth Third

$24.62

-0.33 (-1.32%)

FCX

Freeport McMoRan

$12.51

0.275 (2.25%)

NLSN

Nielsen

$41.66

0.66 (1.61%)

CNC

Centene

$72.16

1.52 (2.15%)

PHM

PulteGroup

$23.06

-0.26 (-1.11%)

JBLU

JetBlue

$21.53

0.14 (0.65%)

XRX

Xerox

$7.01

0.09 (1.30%)

PII

Polaris Industries

$83.16

1.3 (1.59%)

AN

AutoNation

$43.91

1.1 (2.57%)

GPK

Graphic Packaging

$13.52

-0.025 (-0.18%)

RAD

Rite Aid

$3.76

-0.045 (-1.18%)

TUP

Tupperware Brands

$65.58

1.355 (2.11%)

EAT

Brinker

$45.67

1.01 (2.26%)

AKS

AK Steel

$7.15

0.425 (6.32%)

SVU

Supervalu

$3.86

0.02 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 03

    May

  • 03

    May

  • 03

    May

  • 03

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 11

    May

  • 12

    May

  • 23

    May

  • 24

    May

  • 24

    May

  • 25

    May

  • 31

    May

  • 06

    Jun

  • 14

    Jun

  • 20

    Jun

  • 26

    Jun

TEF

Telefonica

$11.38

0.48 (4.40%)

14:45
04/24/17
04/24
14:45
04/24/17
14:45
Periodicals
Telefonica eyes possible IPO of O2 as early as year end, Bloomberg says »

Telefonica is weighing an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$64.70

-0.11 (-0.17%)

, ESRX

Express Scripts

$66.46

-0.59 (-0.88%)

14:45
04/24/17
04/24
14:45
04/24/17
14:45
Earnings
Notable companies reporting after market close »

Notable companies…

TMUS

T-Mobile

$64.70

-0.11 (-0.17%)

ESRX

Express Scripts

$66.46

-0.59 (-0.88%)

CCI

Crown Castle

$94.37

-1.165 (-1.22%)

AMP

Ameriprise

$132.30

3.86 (3.01%)

NEM

Newmont Mining

$34.05

-0.08 (-0.23%)

CDNS

Cadence Design

$32.88

0.11 (0.34%)

ZION

Zions Bancorp

$40.85

-0.23 (-0.56%)

RRC

Range Resources

$27.55

0.075 (0.27%)

AA

Alcoa

$32.86

1.16 (3.66%)

CR

Crane

$77.98

1.44 (1.88%)

OI

Owens-Illinois

$21.35

0.84 (4.10%)

SLCA

U.S. Silica

$41.60

1.09 (2.69%)

SWFT

Swift Transportation

$25.31

0.93 (3.81%)

RMBS

Rambus

$12.94

-0.07 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 04

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 11

    May

  • 18

    May

  • 31

    May

  • 06

    Jun

  • 13

    Jun

NTAP

NetApp

$39.49

-0.82 (-2.03%)

14:42
04/24/17
04/24
14:42
04/24/17
14:42
Recommendations
NetApp analyst commentary  »

SolidFire CEO departure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

VALE

Vale

$8.78

0.1962 (2.29%)

14:31
04/24/17
04/24
14:31
04/24/17
14:31
Options
4K VALE Apr 28th 9 calls trade for 14c »

4K VALE Apr 28th 9 calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$134.32

0.91 (0.68%)

14:30
04/24/17
04/24
14:30
04/24/17
14:30
Hot Stocks
McDonald's USA launches new uniforms »

McDonald's USA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 31

    May

SRPT

Sarepta

$32.61

0.07 (0.22%)

14:26
04/24/17
04/24
14:26
04/24/17
14:26
Recommendations
Sarepta analyst commentary  »

Sarepta drugs get FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$52.09

0.822 (1.60%)

14:21
04/24/17
04/24
14:21
04/24/17
14:21
Options
Metlife calls active driven by spread trading »

Metlife calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 13

    Jun

$NSD

NASDAQ Market Internals

14:17
04/24/17
04/24
14:17
04/24/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
04/24/17
04/24
14:16
04/24/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCTT

Ultra Clean

$16.11

0.01 (0.06%)

14:15
04/24/17
04/24
14:15
04/24/17
14:15
Hot Stocks
Breaking Hot Stocks news story on Ultra Clean »

Ultra Clean rallies 4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

  • 10

    May

  • 30

    May

PPG

PPG

$107.50

1.56 (1.47%)

, AKZOY

AkzoNobel

$27.96

-0.11 (-0.39%)

14:10
04/24/17
04/24
14:10
04/24/17
14:10
Hot Stocks
Elliott continues to recommend AkzoNobel engage with PPG »

Elliott, a private…

PPG

PPG

$107.50

1.56 (1.47%)

AKZOY

AkzoNobel

$27.96

-0.11 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$17.78

0.2916 (1.67%)

14:08
04/24/17
04/24
14:08
04/24/17
14:08
Periodicals
Square acquires Yik Yak team for under $3M, Bloomberg says »

Square has taken over the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 16

    May

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

ARNC

Arconic

$26.13

0.13 (0.50%)

14:07
04/24/17
04/24
14:07
04/24/17
14:07
Hot Stocks
Arconic postpones annual meeting amid talks with Elliott »

Arconic announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

DIS

Disney

$113.93

-0.515 (-0.45%)

, SBGI

Sinclair Broadcast

$39.90

-0.45 (-1.12%)

14:06
04/24/17
04/24
14:06
04/24/17
14:06
Hot Stocks
Disney says signs over 160 ABC stations to over-the-top clearinghouse effort »

Disney (DIS) ABC…

DIS

Disney

$113.93

-0.515 (-0.45%)

SBGI

Sinclair Broadcast

$39.90

-0.45 (-1.12%)

SSP

E.W. Scripps

$22.15

-0.04 (-0.18%)

TGNA

Tegna

$25.70

-0.13 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 02

    May

  • 03

    May

  • 05

    May

  • 09

    May

FMSA

Fairmount Santrol

$5.10

0.02 (0.39%)

14:06
04/24/17
04/24
14:06
04/24/17
14:06
Options
Fairmount Santrol call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

ARNC

Arconic

$26.12

0.12 (0.46%)

14:05
04/24/17
04/24
14:05
04/24/17
14:05
Hot Stocks
Arconic willing to nominate Elliott direct nominees to board »

Arconic announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

PUGOY

Peugeot

$19.40

-0.13 (-0.67%)

, VLKAY

Volkswagen

$30.84

-0.194 (-0.63%)

14:03
04/24/17
04/24
14:03
04/24/17
14:03
Periodicals
France to investigate PSA over alleged diesel emissions cheating, Reuters says »

French prosecutors have…

PUGOY

Peugeot

$19.40

-0.13 (-0.67%)

VLKAY

Volkswagen

$30.84

-0.194 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.